Home › Trial NCT03357289
Mix Vaccine for Metastatic Kidney Cancer
- Trial IDNCT03357289
- StatusCompleted
- PhasePhase 1/2
- Study typeInterventional
- SponsorFuda Cancer Hospital, Guangzhou
- Enrollment30
- Start date2017-11-30
- ConditionsMetastasis From Malignant Tumor of Kidney (Disorder) · Reaction - Mixed Vaccine
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.